Le Lézard
Classified in: Health, Science and technology, Business
Subject: BOARD OF DIRECTORS

Ascent Industries Announces That Annabeth Rose Joins as Operations Director-Oregon


VANCOUVER, British Columbia, July 18, 2019 (GLOBE NEWSWIRE) -- Ascent Industries Corp. (CSE: ASNT) ("Ascent") announces Annabeth Rose is joining the new Management Team to lead operations at the Portland, Oregon facility. Annabeth brings 15 years of laboratory experience with expertise in building and leading teams, and establishing sophisticated quality assurance systems. She has over five years in the cannabis industry and was Vice President of the Oregon Cannabis Laboratory Association. A published scientist, Annabeth brings exceptional insight to Ascent as the company rebuilds the Team for the future. Annabeth's undergraduate studies had an emphasis in cellular and molecular biology at University of Nevada, Reno. She also studied at the University of Reading, England. Annabeth's experiences have led start-ups in accreditation, licensing, business planning and number of high-level certifications. 

Ascent looks forward to Annabeth's leadership and scientific guidance as Ascent reinvigorates the Portland facility's operations. "I am excited to welcome Annabeth as Ascent continues to build the new Management Team that will deliver on our vision of a world that lives better through cannabis" said CEO Paul Dillman.

About Ascent Industries Corp.
The Company's operations currently include facilities Oregon and Nevada in the United States. In the United States, the Company holds licenses in Oregon (for processing and for distribution of cannabis to any licensed entity in the state) and in Nevada (for cultivation and for production, processing and wholesale distribution of cannabis).

THE CANADIAN SECURITIES EXCHANGE (THE "CSE") HAS NEITHER APPROVED NOR DISAPPROVED THE CONTENTS OF THIS PRESS RELEASE. NEITHER THE CSE OR ITS MARKET REGULATOR (AS THAT TERM IS DEFINED IN THE POLICIES OF THE CSE) ACCEPTS RESPONSIBILITY FOR THE ADEQUACY OR ACCURACY OF THIS RELEASE.

CAUTIONARY NOTE REGARDING FORWARD-LOOKING INFORMATION:
This news release contains "forward-looking information" and "forward-looking statements" (collectively, "forward-looking statements") within the meaning of the applicable Canadian securities legislation. All statements, other than statements of historical fact, are forward-looking statements and are based on expectations, estimates and projections as at the date of this news release. Any statement that involves discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, assumptions, future events or performance (often but not always using phrases such as "expects", or "does not expect", "is expected", "anticipates" or "does not anticipate", "plans", "budget", "scheduled", "forecasts", "estimates", "believes" or "intends" or variations of such words and phrases or stating that certain actions, events or results "may" or "could", "would", "might" or "will" be taken to occur or be achieved) are not statements of historical fact and may be forward-looking statements. In this news release, forward-looking statements relate, among other things, the uncertainty involved in the timing of the completion of the Annual Filings. Forward-looking statements are necessarily based upon a number of estimates and assumptions that, while considered reasonable, are subject to known and unknown risks, uncertainties, and other factors which may cause the actual results and future events to differ materially from those expressed or implied by such forward-looking statements. Such factors include, but are not limited to general business, economic, competitive, political and social uncertainties. There can be no assurance that forward-looking statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on the forward-looking statements and information contained in this news release. Except as required by law, Ascent assumes no obligation to update the forward-looking statements of beliefs, opinions, projections, or other factors, should they change, except as required by law.

For further information:

Paul Dillman
ir@ascentindustries.com


These press releases may also interest you

at 19:45
Suncoast Neuroscience Associates is recruiting for a clinical research study to evaluate an investigational medication in people diagnosed with Parkinson's disease who are experiencing symptoms such as seeing things/hearing things that may not...

at 18:21
This summer, Aflac, the leader in supplemental insurance sales at U.S. worksites, is bringing My Special Aflac Ducks to Roswell Park Comprehensive Cancer Center. My Special Aflac Duck, designed by Sproutel, is a social robot that uses medical play,...

at 18:00
Concord Medical Services Holdings Limited ("Concord Medical" or the "Company") , a specialty hospital management group and an operator of the network of radiotherapy and diagnostic imaging centers in China, today announced its unaudited consolidated...

at 17:38
Altaire Pharmaceuticals, Inc., announces today that it is correcting its 08.22.19 Announcement of a Voluntary Recall for Veterinary Ophthalmic drug products and lots, within expiry, identified below.  Corrections are being made only for the...

at 17:05
Golden Leaf Holdings Ltd. ("Golden Leaf" or the "Company") , a pioneer cannabis oil solutions company and dispensary operator built around recognized brands, has announced the completion of the debenture payments. On July 2, 2019, the Company...

at 17:00
"Patients and Providers need an easy, affordable way to understand their genetic data, monitor their health outcomes and obtain vetted personalized products. Our partnership with Breakthrough Genomics will assure all users have access to actionable...



News published on 18 july 2019 at 14:35 and distributed by: